©Reuters.
San Juan Capistrano, California – ensign group Inc. (NASDAQ: NASDAQ:), a diversified provider of healthcare services, announced the acquisition of three skilled nursing facilities across Kansas and Colorado. The transaction, which included the purchase and operation of the property, was completed on March 1, 2024.
The newly acquired Atchison Senior Village Rehabilitation and Nursing Center in Kansas has 45 beds and is now part of Ensign's portfolio. The property was purchased by a subsidiary of Ensign's captive real estate company, Standard Bearer Healthcare REIT, Inc. Ensign CEO Barry Port expressed enthusiasm about the addition to the Kansas market, citing strong leadership and growth potential.
In separate but simultaneous transactions, Ensign affiliates acquired Park Post Acute, a 135-bed facility in Parker, Colorado, and Oakwood, a 170-bed facility in Lakewood, Colorado. Acquired Care and Rehabilitation. These acquisitions bring the company's total footprint of operations to 302 medical facilities, including 27 senior citizen facility operations across 14 states. Ensign's subsidiaries currently own 114 real estate assets.
Port also said Ensign continues to actively pursue healthcare real estate acquisition and leasing opportunities for both high-performing and underperforming companies.
Ensign Group's independent operating subsidiaries provide a variety of services, including skilled nursing care, senior living, and a variety of rehabilitation therapies. The company has operations in multiple states, including Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin.
This expansion reflects Ensign's continued strategy to expand its portfolio within the healthcare industry. The company's statement indicates its commitment to improving the quality of care and services provided at the newly acquired facilities. The information in this article is based on the press release.
This article was generated with the help of AI and reviewed by an editor. Please see our Terms of Use for more information.
